4.7 Article

Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme

Related references

Note: Only part of the references are listed.
Letter Clinical Neurology

Does the choice of antiepileptic drug have an impact on the survival of glioblastoma multiforme?

Greg Guthrie et al.

BRITISH JOURNAL OF NEUROSURGERY (2013)

Article Oncology

Combination therapy of cilengitide with belotecan against experimental glioblastoma

Young-Hoon Kim et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

Article Oncology

Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival

Christopher A. Barker et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Oncology

Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation

Krista A. Van Nifterik et al.

JOURNAL OF NEURO-ONCOLOGY (2012)

Article Genetics & Heredity

Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation

Ching-Hsein Chen et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2011)

Review Clinical Neurology

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

Melanie S. M. van Breemen et al.

LANCET NEUROLOGY (2007)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)